BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival | British Journal of Cancer
BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas in: European Journal of Endocrinology Volume 165 Issue 3 (2011)
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment - Annals of Oncology
Cancer colorectal markeri tumorali, Cat de credibili sunt markerii tumorali?
Emerging actionable targets to treat therapy-resistant colorectal cancers
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies | Cell Death & Disease
Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation - ScienceDirect
Cancer colorectal markeri tumorali, Cat de credibili sunt markerii tumorali?
BRAF Gene Mutation Tests: Reference Range, Interpretation, Collection and Panels
Early differential responses elicited by BRAFV600E in adult mouse models | Cell Death & Disease
Frontiers | The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
Histologic variants and rates of BRAF mutation. The percentage given... | Download Scientific Diagram
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer | npj Precision Oncology
:max_bytes(150000):strip_icc()/braf-testing-4769863_round3-e1f8b9a568c845b7946f6f16ee0497d1.png "BRAF Testing: Uses, Side Effects, Procedure, Results")
BRAF Testing: Uses, Side Effects, Procedure, Results
Cancers | Free Full-Text | Targeting BRAF and RAS in Colorectal Cancer | HTML
Results and Performance of the Idylla NRAS-BRAF Mutation Test against... | Download Scientific Diagram
Cancers | Free Full-Text | Current Advances in the Treatment of BRAF-Mutant Melanoma | HTML
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine
